Clinical Trial Update: Twice Daily Altabax Application for the Treatment of Uncomplicated Soft Tissue Infection [Phase 4]

View source ↗

Summary

Phase 4 trial update on twice-daily application of Altabax for uncomplicated soft tissue infections, including impetigo and folliculitis, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Folliculitis
• Impetigo
• Soft Tissue Infection

Drugs mentioned

• Altabax (retapamulin)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Impetigo, Folliculitis | Phase 4 | Status: COMPLETED | Results posted: 2016-02-17